Biological impact of targeted dialysate calcium changes in haemodialysis patients: The key role of parathyroid hormone

Nephrology Dialysis Transplantation

Volumn 28, Issue 1, 2013, Pages 176-182

  Jean, Guillaume ^a   Mayor, Brice ^a   Hurot, Jean Marc ^a   Deleaval, Patrik ^a   Lorriaux, Christie ^a   Zaoui, Eric ^b   Chazot, Charles ^a  

^a NephroCare Tassin Charcot ^*  (France)

^b Laboratoire du Grand Vallon   (France)

Author keywords

alkaline phosphatases; dialysate calcium; haemodialysis; parathyroid hormone; phosphorus

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; CINACALCET; COLECALCIFEROL; PARATHYROID HORMONE; PHOSPHATE; SEVELAMER;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM DIALYSATE LEVEL; DIALYSATE LEVEL; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; CALCIUM; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84872235992     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs119     Document Type: Article

References (34)

1. Moe SM, Drueke TB. The KDIGO guideline on dialysate calcium and patient outcomes: need for hard evidence. Kidney Int 2011; 79: 478; author reply 478-479.
2. Gotch FA, Kotanko P, Thijssen S et al. The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients. Kidney Int 2010; 78: 343-350.
3. Basile C, Libutti P, Lomonte C. The diffusion gradient between the ionized calcium concentration in the dialysate and in the blood is the main driving force of the net calcium mass balance during haemodialysis. Nephrol Dial Transplant 2010; 25: 1356-1357.
4. Regan RJ, Peacock M, Rosen SM et al. Effect of dialysate calcium concentration on bone disease in patients on hemodialysis. Kidney Int 1976; 10: 246-255.
5. Kyriazis J, Glotsos J, Bilirakis L et al. Dialysate calcium profiling during hemodialysis: use and clinical implications. Kidney Int 2002; 61: 276-287.
6. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (4 Suppl 3): 1-201.
7. KDIGO CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone disorder (CKD-MBD). Kidney Int Suppl 2009; 76 (Suppl 113): S1-130.
8. Jean G, Vanel T, Terrat JC et al. Treating mineral metabolism disorders in patients undergoing long hemodialysis: a search for an optimal strategy. Hemodial Int 2009; 13: 526-532.
9. Johnson WJ. Optimum dialysate calcium concentration during maintenance hemodialysis. Nephron 1976; 17: 241-258.
10. Malberti F, Montoli A, Surian M. Long-term effect of low calcium dialysate on parathyroid activity in dialysis patients treated with calcium carbonate as a phosphate binder. Nephrol Dial Transplant 1989; 4: 758-759.
11. Locatelli F, Cannata-Andia JB, Drueke TB et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 2002; 17: 723-731.
12. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187.
13. Argiles A, Mourad G. How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism?. Nephrol Dial Transplant 1998; 13 (Suppl 3): 62-64.
14. Fabrizi F, Bacchini G, Di Filippo S et al. Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. Nephron 1996; 72: 530-535.
15. van Kuijk WH, Mulder AW, Peels CH et al. Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis. Clin Nephrol 1997; 47: 190-196.
16. Nappi SE, Virtanen VK, Saha HH et al. QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int 2000; 57: 2117-2122.
17. Jespersen B, Jensen JD, Nielsen HK et al. Comparison of calcium carbonate and aluminium hydroxide as phosphate binders on biochemical bone markers, PTH(1-84), and bone mineral content in dialysis patients. Nephrol Dial Transplant 1991; 6: 98-104.
18. Moe SM, Chertow GM, Coburn JW et al. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 2005; 67: 760-771.
19. Tsukamoto Y, Nomura M, Takahashi Y et al. The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 1991; 57: 23-28.
20. Molina Vila P, Sanchez Perez P, Garrigos Almerich E et al. Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5 to 3 mEq/L in nonhypercalcemic hemodialysis patients. Hemodial Int 2008; 12: 73-79.
21. Jean G, Chazot C, Charra B. Biological evolution of renal osteodystrophy after decreasing dialysate calcium from 1.75 to 1.6 mmol/l. Clin Nephrol 2002; 57: 91-92.
22. Hou SH, Zhao J, Ellman CF et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991; 18: 217-224.
23. Spasovski G, Gelev S, Masin-Spasovska J et al. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone 2007; 41: 698-703.
24. Gauci C, Moranne O, Fouqueray B et al. Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 2008; 19: 1592-1698.
25. Palmer BF. Individualizing the dialysate in the hemodialysis patient. Semin Dial 2001; 14: 41-49.
26. Lindley EJ. Should dialysate calcium concentration be standardised or individualised?. J Ren Care 2009; 35 (Suppl 1): 101-106.
27. Drueke TB, Touam M. Calcium balance in haemodialysis-do not lower the dialysate calcium concentration too much (con part). Nephrol Dial Transplant 2009; 24: 2990-2993.
28. Lindsay RM, Alhejaili F, Nesrallah G et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003; 42 (1 Suppl): 24-29.
29. London GM, Marchais SJ, Guerin AP et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-1835.
30. LeBeouf A, Mac-Way F, Utescu MS et al. Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant 2009; 24: 3788-3794.
31. Jean G, Lataillade D, Genet L et al. Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study. Hemodial Int 2011; 15: 485-492.
32. Jean G, Bresson E, Terrat JC et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 2009; 24: 948-955.
33. Jean G, Bresson E, Lorriaux C. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin Pract 2012; in press.
34. Jean G, Terrat JC, Vanel T et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 2009; 24: 2792-2796.